GeminIQ Website Logo

Viewing OFIX free

Subscribe for full history, 90+ metrics, screener, watchlist...

Orthofix Medical Inc.

OFIX

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
10412082636658833026273334
Restricted Cash Current
11333333335-
Accounts Receivable Net Current
136138136131130132135125125126128114
Inventory Net
184178172174173174189206210219222222
Prepaid Expense And Other Assets Current
212524232524232322253224
Assets Current
446462417394396390433386386399420394
Property Plant And Equipment Net
131125129130129131140147154158159153
Intangible Assets Net Excluding Goodwill
66697376798199105108113117121
Goodwill
195195195195195195195195195195195195
Other Assets Noncurrent
353537383826263539413343
Assets
873887851833837823893868882906925906
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
645558504545494750575853
Long Term Debt Current
--0---06531-
Finance Lease Liability Current
-01111111111
Other Liabilities Current
93106111109102981191081009010599
Liabilities Current
157161170160148144169162156151165153
Long Term Debt Noncurrent
2222211571571571571571121131159370
Finance Lease Liability Noncurrent
-1317171718181818181919
Other Liabilities Noncurrent
525656565646475049525049
Liabilities
444451401390379365390342336336327290
Stockholders Equity
Common Stock Value
444444444444
Additional Paid In Capital Common Stock
830820814804797786780770765753746742
Retained Earnings Accumulated Deficit
-405-389-368-366-343-329-276-247-220-186-150-128
Accumulated Other Comprehensive Income Loss Net Of…
-00111-3-4-1-3-1-1-2
Stockholders Equity
429435450442458458503526546570599615
Liabilities And Stockholders Equity
873887851833837823893868882906925906
Allowance For Doubtful Accounts Receivable Current
1198999788877
Common Stock Par Or Stated Value Per Share
0.10.10.10.10.10.10.10.10.10.10.10.1
Common Stock Shares Authorized
100100100100100100100100100100100100
Common Stock Shares Issued
414040403939383838373737
Shares Outstanding
414040403939383838373737

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-25.48%-21.38%-9.57%---------
2025-6.72%-8.04%-6.55%21.69%16.08%29.73%8.20%2.49%-10.36%-8.63%-0.31%-5.80%
2024-1.15%-4.54%18.86%0.00%-12.16%-8.94%7.19%-3.79%0.71%-5.03%-25.59%-30.67%
2023---18.49%-28.40%-40.20%-6.24%13.66%21.75%11.69%-0.08%14.54%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.84
2.87
2.45
2.47
2.67
2.71
2.57
2.39
2.48
2.65
2.54
2.58
Quick Ratio
1.53
1.61
1.30
1.23
1.34
1.33
1.31
0.97
0.99
1.03
1.00
0.97
Working Capital
289.12M
300.49M
246.37M
234.32M
247.45M
246.19M
264.66M
224.32M
230.10M
248.36M
255.22M
241.17M
Leverage & Debt
Debt to Equity
1.03
1.04
0.89
0.88
0.83
0.80
0.78
0.65
0.62
0.59
0.55
0.47
Interest Coverage TTM
-1.88
-2.52
-4.66
-3.33
-3.33
-3.52
-2.86
-4.76
-6.23
-9.14
-16.12
-30.24
Debt Ratio
0.51
0.51
0.47
0.47
0.45
0.44
0.44
0.39
0.38
0.37
0.35
0.32
Efficiency & Turnover
Asset Turnover TTM
0.97
0.97
0.94
0.96
0.94
0.93
0.88
0.88
0.87
0.83
1.08
0.99
Days Sales Outstanding TTM
58.13
59.62
60.02
57.03
57.50
58.41
59.99
55.61
56.21
57.37
51.56
51.81
Receivables Turnover TTM
6.28
6.12
6.08
6.40
6.35
6.25
6.08
6.56
6.49
6.36
7.08
7.05
Per Share Metrics
Diluted EPS TTM
-1.51
-1.48
-2.33
-3.00
-3.13
-3.65
-3.30
-3.09
-3.17
-3.35
-4.12
-3.66
Free Cash Flow Per Share TTM
-0.58
-0.11
-0.03
0.10
0.19
-0.10
-0.21
-1.15
-1.90
-2.38
-2.89
-2.35
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
71.31%
70.75%
68.83%
68.27%
67.37%
67.15%
68.28%
68.05%
67.18%
66.20%
65.13%
65.65%
Operating Profit Margin TTM
-4.70%
-5.69%
-9.90%
-11.42%
-11.77%
-12.95%
-10.58%
-11.66%
-12.57%
-14.31%
-18.63%
-19.72%
Net Profit Margin TTM
-7.41%
-7.27%
-11.21%
-14.56%
-15.29%
-17.78%
-15.76%
-15.18%
-15.62%
-16.64%
-20.28%
-20.39%
Growth Metrics
Net Revenue Growth (1Y)
2.99%
2.59%
2.85%
4.31%
4.84%
5.85%
7.08%
17.32%
28.94%
43.54%
62.06%
44.20%
Net Income Growth (1Y)
-50.11%
-58.06%
-26.83%
0.08%
2.67%
13.12%
-16.78%
-12.66%
1.99%
65.92%
666.60%
199.53%
EPS Growth (1Y)
-51.82%
-59.37%
-29.54%
-3.14%
-1.18%
8.94%
-19.84%
-15.47%
-1.38%
57.10%
318.55%
61.56%
Valuation Metrics
P/E TTM
-6.06
-7.73
-6.51
-4.89
-3.56
-4.47
-5.28
-5.05
-4.18
-4.33
-3.27
-3.51
P/B TTM
0.87
1.07
1.33
1.32
0.96
1.39
1.32
1.14
0.92
0.96
0.83
0.78
P/S TTM
0.45
0.56
0.73
0.71
0.54
0.79
0.83
0.77
0.65
0.72
0.66
0.72
Market Cap
373.88M
463.96M
600.37M
582.17M
440.44M
639.16M
665.81M
601.18M
504.15M
548.00M
495.11M
479.02M
Enterprise Value
491.66M
565.13M
676.57M
677.35M
532.67M
738.86M
823.73M
690.34M
596.52M
639.96M
557.07M
516.05M
Calculated Values
Free Cash Flow TTM
-23.90M
-4.42M
-1.28M
3.84M
7.69M
-3.94M
-7.95M
-44.40M
-72.15M
-89.66M
-106.01M
-87.61M
Net Debt
117.78M
101.17M
76.20M
95.17M
92.24M
99.70M
157.92M
89.15M
92.37M
91.96M
61.96M
37.03M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-18Sale
Owner: Mcpherron, Aviva
Title: Pres, Global Ops & Qual
Shares: 3,670
Price/Share: $9.38
Value: $34,424.60
Shares Owned: 66,330
Relationship: Officer
Ownership: Direct
2026-05-22Sale
Owner: Juniper, Investment Compa…
Title: -
Shares: 242,000
Price/Share: $10.70
Value: $2,589,400.00
Shares Owned: 3,461,216
Relationship: TenPercentOwner
Ownership: Indirect
2026-05-07Purchase
Owner: Engine, Jet Capital, L.P.…
Title: -
Shares: 30,000
Price/Share: $12.18
Value: $365,400.00
Shares Owned: 3,848,573
Relationship: TenPercentOwner
Ownership: Indirect
2026-05-07Purchase
Owner: Henneman, John B Iii
Title: -
Shares: 5,000
Price/Share: $12.26
Value: $61,300.00
Shares Owned: 90,809
Relationship: Director
Ownership: Direct
2026-04-16Sale
Owner: Cedron, Jorge Andres
Title: CLO
Shares: 3,743
Price/Share: $12.82
Value: $47,985.26
Shares Owned: 59,006
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
85.99%
Inst. Shares: 34,784,916
Shares Outstanding: 40,450,000
2025-12-31
87.46%
Inst. Shares: 34,634,953
Shares Outstanding: 39,602,345
2025-09-30
87.37%
Inst. Shares: 34,743,690
Shares Outstanding: 39,766,000
2025-06-30
89.88%
Inst. Shares: 35,503,830
Shares Outstanding: 39,501,000
2025-03-31
83.12%
Inst. Shares: 32,572,623
Shares Outstanding: 39,188,000

Orthofix Medical Inc. (OFIX) — SEC Financial Statements & Analysis

Orthofix Medical Inc. (OFIX) is a surgical & medical instruments & apparatus company. Orthofix Medical Inc. trades on Nasdaq as: OFIX. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Orthofix Medical Inc. reported a 2.99% year-over-year revenue growth, a Gross Profit Margin of 71.31% (TTM), a Debt-to-Equity ratio of 1.03x, a Price-to-Sales (P/S) ratio of 0.45x (TTM), a Price-to-Book (P/B) ratio of 0.87x (TTM), at a market cap of $373.88M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
2.99%
Gross Profit Margin TTM
71.31%
Debt To Equity
1.03x
P/S TTM
0.45x
P/B TTM
0.87x
Market Cap
$373.88M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Orthofix Medical Inc. in?

Orthofix Medical Inc. (OFIX) operates in the Surgical & Medical Instruments & Apparatus industry.

What is OFIX's market cap?

Orthofix Medical Inc. (OFIX) has a market capitalization of $373.88M as of 2026-06-30.

What exchange does OFIX trade on?

Orthofix Medical Inc. (OFIX) trades on the Nasdaq.

Wall Street's data.
Main Street's price.